ConductScience.org, home

Paper22628

Bupropion hydrochloride ((+/-) alpha-t-butylamino-3-chloropropiophenone HCl): a novel antidepressant agent.

Soroko FE and 4 others. J Pharm Pharmacol, 1977. Cited by 125 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Bupropion hydrochloride ((+/-) alpha-t-butylamino-3-chloropropiophenone HCl): a novel antidepressant agent. Papers, record 22628. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22628

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bupropion hydrochloride ((+/-) alpha-t-butylamino-3-chloropropiophenone HCl): a novel antidepressant agent.
PubMed
Journal
J Pharm Pharmacol
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
125
iCite
Relative citation ratio, by iCite
5.57
iCite
Revised in PubMed
2019-07-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Soroko FEF E
2Mehta NBN B
3Maxwell RAR A
4Ferris RMR M
5Schroeder DHD H

Source PubMed

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antidepressive AgentsMajor topic
PropiophenonesMajor topic
Amitriptyline
Animals
Behavior, Animal
Brain Chemistry
Cats
Dextroamphetamine
Dogs
Guinea Pigs
Hemodynamics
In Vitro Techniques
Lethal Dose 50
Methylphenidate
Mice
Monoamine Oxidase Inhibitors
Muscle Contraction
Muscle, Smooth
Rabbits
Rats
Sleep
Tetrabenazine

Source PubMed

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 125 citations.

PMIDTitleJournalYearIn PapersSource
38,671,986Synthetic Cathinones: Epidemiology, Toxicity, Potential for Abuse, and Current Public Health Perspective.Brain Sci2024https://conductscience.org/library/papers/38671986PubMed
35,512,805Stereoselective Metabolism of Bupropion to Active Metabolites in Cellular Fractions of Human Liver and Intestine.Drug Metab Dispos2023https://conductscience.org/library/papers/35512805PubMed
35,457,736An Update on the Implications of New Psychoactive Substances in Public Health.Int J Environ Res Public Health2022https://conductscience.org/library/papers/35457736PubMed
34,100,120An updated review on synthetic cathinones.Arch Toxicol2021https://conductscience.org/library/papers/34100120PubMed
32,249,347Designer drugs: mechanism of action and adverse effects.Arch Toxicol2020https://conductscience.org/library/papers/32249347PubMed
31,612,411The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression.Mol Biol Rep2020https://conductscience.org/library/papers/31612411PubMed
30,925,718Molecular Toxicological Mechanisms of Synthetic Cathinones on C2C12 Myoblasts.Int J Mol Sci2019https://conductscience.org/library/papers/30925718PubMed
27,255,113Chiral Plasma Pharmacokinetics and Urinary Excretion of Bupropion and Metabolites in Healthy Volunteers.J Pharmacol Exp Ther2016https://conductscience.org/library/papers/27255113PubMed
26,802,129Stereoselective Glucuronidation of Bupropion Metabolites In Vitro and In Vivo.Drug Metab Dispos2016https://conductscience.org/library/papers/26802129PubMed
25,337,378Microinfusion of bupropion inhibits putative GABAergic neuronal activity of the ventral tegmental area.Basic Clin Neurosci2014https://conductscience.org/library/papers/25337378PubMed
25,120,365A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorder.Neuropsychiatr Dis Treat2014https://conductscience.org/library/papers/25120365PubMed
23,455,599Acute behavioural effects of bupropion and naltrexone, alone and in combination, in non-deprived male rats presented with palatable mash.Psychopharmacology (Berl)2013https://conductscience.org/library/papers/23455599PubMed
17,293,887Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission.Br J Pharmacol2007https://conductscience.org/library/papers/17293887PubMed
8,099,801Dopamine and depression.J Neural Transm Gen Sect1993https://conductscience.org/library/papers/8099801PubMed
7,862,832Canine cataplexy is preferentially controlled by adrenergic mechanisms: evidence using monoamine selective uptake inhibitors and release enhancers.Psychopharmacology (Berl)1993https://conductscience.org/library/papers/7862832PubMed
6,817,770The effects of bupropion, a new antidepressant drug, and diazepam, and their interaction in man.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6817770PubMed
6,805,494Bupropion fails to affect plasma prolactin and growth hormone in normal subjects.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6805494PubMed
6,804,243Pharmacokinetics of bupropion, a novel antidepressant agent, following oral administration to healthy subjects.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/6804243PubMed
6,788,059Failure of bupropion to affect the response to tyramine in man.Br J Clin Pharmacol1981https://conductscience.org/library/papers/6788059PubMed
6,768,086Stimulus properties of antidepressants in the rat.Psychopharmacology (Berl)1980https://conductscience.org/library/papers/6768086PubMed

See all 29 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22628

GET https://conductscience.org/api/papers/v1/22628/cited_by?page=2